{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:26:21Z","timestamp":1746303981475,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00277-022-04809-8","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T14:02:28Z","timestamp":1646488948000},"page":"1617-1619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Successful treatment for diffuse large B-cell lymphoma in a Japanese adolescent with PIK3CD germ-line mutation: stem cell transplantation after reduced-intensity conditioning"],"prefix":"10.1007","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7937-5512","authenticated-orcid":false,"given":"Hiroshi","family":"Yagasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kanezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Sugitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"key":"4809_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1744-313X.2006.00627.x","volume":"33","author":"ST Jou","year":"2006","unstructured":"ST Jou YH Chien YH Yang TC Wang SD Shyur CC Chou ML Chang DT Lin KH Lin BL Chiang 2006 Identification of variations in the human phosphoinositide 3-kinase p110delta gene in children with primary B-cell immunodeficiency of unknown aetiology Int J Immunogenet 33 361 369 https:\/\/doi.org\/10.1111\/j.1744-313X.2006.00627.x","journal-title":"Int J Immunogenet"},{"key":"4809_CR2","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3389\/fimmu.2017.02005","volume":"8","author":"JM Carpier","year":"2017","unstructured":"JM Carpier CL Lucas 2017 Epstein-Barr virus susceptibility in activated PI3K\u03b4 syndrome (APDS) immunodeficiency Front Immunol 8 2005 https:\/\/doi.org\/10.3389\/fimmu.2017.02005","journal-title":"Front Immunol"},{"key":"4809_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12016-019-08738-9","volume":"59","author":"M Jamee","year":"2020","unstructured":"M Jamee S Moniri M Zaki-Dizaji P Olbrich R Yazdani F Jadidi-Niaragh F Aghamahdi H Abolhassani AM Condliffe A Aghamohammadi G Azizi 2020 Clinical, immunological, and genetic features in patients with activated PI3K\u03b4 syndrome (APDS): a systematic review Clin Rev Allergy Immunol 59 323 333 https:\/\/doi.org\/10.1007\/s12016-019-08738-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"4809_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fimmu.2018.00543","volume":"9","author":"ME Maccari","year":"2018","unstructured":"ME Maccari H Abolhassani A Aghamohammadi A Aiuti O Aleinikova C Bangs S Baris F Barzaghi H Baxendale M Buckland  2018 Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase \u03b4 syndrome: the European Society for Immunodeficiencies-activated phosphoinositide 3-kinase \u03b4 syndrome registry Front Immunol 9 543 https:\/\/doi.org\/10.3389\/fimmu.2018.00543","journal-title":"Front Immunol"},{"key":"4809_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"TI Coulter A Chandra CM Bacon J Babar J Curtis N Screaton JR Goodlad G Farmer CL Steele TR Leahy  2017 Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study J Allergy Clin Immunol 139 597 606.e4 https:\/\/doi.org\/10.1016\/j.jaci.2016.06.021","journal-title":"J Allergy Clin Immunol"},{"key":"4809_CR6","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1016\/j.jaip.2021.07.044","volume":"9","author":"J Oh","year":"2021","unstructured":"J Oh E Garabedian R Fuleihan C Cunningham-Rundles 2021 Clinical manifestations and outcomes of activated phosphoinositide 3-kinase \u03b4 syndrome from the USIDNET cohort J Allergy Clin Immunol Pract 9 4095 4102 https:\/\/doi.org\/10.1016\/j.jaip.2021.07.044","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4809_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jaci.2018.04.032","volume":"143","author":"T Okano","year":"2019","unstructured":"T Okano K Imai Y Tsujita N Mitsuiki K Yoshida C Kamae K Honma K Mitsui-Sekinaka Y Sekinaka T Kato  2019 Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase \u03b4 syndrome type 1 J Allergy Clin Immunol 143 266 275 https:\/\/doi.org\/10.1016\/j.jaci.2018.04.032","journal-title":"J Allergy Clin Immunol"},{"key":"4809_CR8","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","volume":"130","author":"VK Rao","year":"2017","unstructured":"VK Rao S Webster VASH Dalm A \u0160ediv\u00e1 PM Hagen van S Holland SD Rosenzweig AD Christ B Sloth M Cabanski  2017 Effective \u201cactivated PI3K\u03b4 syndrome\u201d-targeted therapy with the PI3K\u03b4 inhibitor leniolisib Blood 130 2307 2316 https:\/\/doi.org\/10.1182\/blood-2017-08-801191","journal-title":"Blood"},{"key":"4809_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature21406","volume":"542","author":"M Compagno","year":"2017","unstructured":"M Compagno Q Wang C Pighi TC Cheong FL Meng T Poggio LS Yeap E Karaca RB Blasco F Langellotto  2017 Phosphatidylinositol 3-kinase \u03b4 blockade increases genomic instability in B cells Nature 542 489 493 https:\/\/doi.org\/10.1038\/nature21406","journal-title":"Nature"},{"key":"4809_CR10","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jaci.2016.09.040","volume":"139","author":"Z Nademi","year":"2017","unstructured":"Z Nademi MA Slatter CC Dvorak B Neven A Fischer F Suarez C Booth K Rao A Laberko J Rodina  2017 Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome J Allergy Clin Immunol 139 1046 1049 https:\/\/doi.org\/10.1016\/j.jaci.2016.09.040","journal-title":"J Allergy Clin Immunol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04809-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04809-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04809-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T09:03:49Z","timestamp":1655370229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04809-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4809"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04809-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"7 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and the 1964 Helsinki Declaration and its later amendments (or comparable ethical standards).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patient and the guardians for the participation and publication of this case study, and this was authorized by the institutional review board of Nihon University Itabashi Hospital (No. RK-201013-14).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}